The Role and Safety of Aluminum Adjuvants in Childhood Vaccines
Authors:
- 25 February 2026
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 157 (3)
Abstract
Aluminum salts have been used as adjuvants in vaccines for nearly a century, enhancing the immune response to purified antigens and ensuring durable protection against serious infectious diseases. Despite their longstanding record of safety and effectiveness, aluminum adjuvants have become a focus of public concern, with claims linking them to developmental, neurologic, allergic, and autoimmune diseases. This review summarizes the immunologic rationale for aluminum adjuvants and evaluates the evidence for proposed safety risks. Aluminum salts have consistently been demonstrated over nearly a century of use to enhance the immune responses elicited by vaccines while also being well tolerated by nearly all who take them. Pharmacokinetic studies show that aluminum released from intramuscular vaccines is slowly absorbed and efficiently cleared by the kidneys, contributing minimally to systemic levels. Large-scale clinical and epidemiologic studies consistently demonstrate no association between aluminum-adjuvanted vaccines and autism spectrum disorder, neurotoxicity, allergic disease, or autoimmune disease. Clinically, vaccines adjuvanted solely with aluminum salts generally do not result in systemic reactogenicity, although local reactions are common. Collectively, the evidence strongly supports the safety of aluminum adjuvants and their necessity in certain vaccines. Clinicians can reassure caregivers that aluminum-containing vaccines provide clear benefits, with risks largely limited to transient local reactions and no systemic toxicity signal in large clinical and epidemiologic studies.Keywords
This publication has 441 references indexed in Scilit:
- The Heritability of Autism Spectrum DisorderJAMA, 2017
- Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune ResponseJAMA, 2015
- Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without AutismJAMA, 2015
- Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous SystemJAMA, 2015
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- Epidemiology of Autism Spectrum Disorders in Adults in the Community in EnglandArchives of General Psychiatry, 2011
- Continuing Increases in Autism Reported to California's Developmental Services SystemArchives of General Psychiatry, 2008
- Advancing Paternal Age and AutismArchives of General Psychiatry, 2006
- Vaccinations and Risk of Central Nervous System Demyelinating Diseases in AdultsArchives of Neurology, 2003
- Diphtheritic PolyneuropathyArchives of Neurology, 2001